In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research

Xiang Qun Xie, Lirong Wang, Junmei Wang, Zhaojun Xie, Peng Yang, Qin Ouyang

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Polypharmacological effect is a prevalent problem for abused substances and is a challenge for research on drug abuse (DA). In silico technologies have emerged as effective approaches to study the interactions between small molecules and their potential targets.We focus on the contemporary resources and computational tools for polypharmacology research on DA. Specifically, we review current in silico techniques for pharmacology profiling of chemical compound(s). As an illustration, we used our developed and implemented chemical genomics tools to explore polydrug addiction networks. Our established cannabinoid molecular information database (CBID or CBLigand), a chemogenomics platform for cannabinoid research, was used to demonstrate the detailed application of these technologies. We also provide our perspective on the challenges in polypharmacology research and possible solutions.The in silico technologies for polypharmacology research can predict possible off-targets to avoid adverse effects, to suggest new targets of approved drugs for drug repurposing, and even to evaluate in silico affinity and selectivity among protein families.

Original languageEnglish (US)
Title of host publicationGeneral Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions
PublisherElsevier Inc.
Pages183-195
Number of pages13
Volume3
ISBN (Electronic)9780128006771
ISBN (Print)9780128006344
DOIs
StatePublished - May 13 2016

Fingerprint

Neuropharmacology
Knowledge Bases
Cannabinoids
Polypharmacology
Computer Simulation
Research
Pharmaceutical Preparations
Technology
Substance-Related Disorders
Drug Repositioning
Chemical Databases
Genomics
Pharmacology
Proteins

Keywords

  • Cannabinoid drug abuse
  • Chemogenomics knowledgebase
  • Molecular docking
  • Systems pharmacology
  • TargetHunter

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Xie, X. Q., Wang, L., Wang, J., Xie, Z., Yang, P., & Ouyang, Q. (2016). In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions (Vol. 3, pp. 183-195). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800634-4.00019-6

In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research. / Xie, Xiang Qun; Wang, Lirong; Wang, Junmei; Xie, Zhaojun; Yang, Peng; Ouyang, Qin.

General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier Inc., 2016. p. 183-195.

Research output: Chapter in Book/Report/Conference proceedingChapter

Xie, XQ, Wang, L, Wang, J, Xie, Z, Yang, P & Ouyang, Q 2016, In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research. in General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. vol. 3, Elsevier Inc., pp. 183-195. https://doi.org/10.1016/B978-0-12-800634-4.00019-6
Xie XQ, Wang L, Wang J, Xie Z, Yang P, Ouyang Q. In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research. In General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3. Elsevier Inc. 2016. p. 183-195 https://doi.org/10.1016/B978-0-12-800634-4.00019-6
Xie, Xiang Qun ; Wang, Lirong ; Wang, Junmei ; Xie, Zhaojun ; Yang, Peng ; Ouyang, Qin. / In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research. General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions. Vol. 3 Elsevier Inc., 2016. pp. 183-195
@inbook{e57d44219ae44c5895a6f17543fe50a4,
title = "In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research",
abstract = "Polypharmacological effect is a prevalent problem for abused substances and is a challenge for research on drug abuse (DA). In silico technologies have emerged as effective approaches to study the interactions between small molecules and their potential targets.We focus on the contemporary resources and computational tools for polypharmacology research on DA. Specifically, we review current in silico techniques for pharmacology profiling of chemical compound(s). As an illustration, we used our developed and implemented chemical genomics tools to explore polydrug addiction networks. Our established cannabinoid molecular information database (CBID or CBLigand), a chemogenomics platform for cannabinoid research, was used to demonstrate the detailed application of these technologies. We also provide our perspective on the challenges in polypharmacology research and possible solutions.The in silico technologies for polypharmacology research can predict possible off-targets to avoid adverse effects, to suggest new targets of approved drugs for drug repurposing, and even to evaluate in silico affinity and selectivity among protein families.",
keywords = "Cannabinoid drug abuse, Chemogenomics knowledgebase, Molecular docking, Systems pharmacology, TargetHunter",
author = "Xie, {Xiang Qun} and Lirong Wang and Junmei Wang and Zhaojun Xie and Peng Yang and Qin Ouyang",
year = "2016",
month = "5",
day = "13",
doi = "10.1016/B978-0-12-800634-4.00019-6",
language = "English (US)",
isbn = "9780128006344",
volume = "3",
pages = "183--195",
booktitle = "General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - In Silico Chemogenomics Knowledgebase and Computational System Neuropharmacology Approach for Cannabinoid Drug Research

AU - Xie, Xiang Qun

AU - Wang, Lirong

AU - Wang, Junmei

AU - Xie, Zhaojun

AU - Yang, Peng

AU - Ouyang, Qin

PY - 2016/5/13

Y1 - 2016/5/13

N2 - Polypharmacological effect is a prevalent problem for abused substances and is a challenge for research on drug abuse (DA). In silico technologies have emerged as effective approaches to study the interactions between small molecules and their potential targets.We focus on the contemporary resources and computational tools for polypharmacology research on DA. Specifically, we review current in silico techniques for pharmacology profiling of chemical compound(s). As an illustration, we used our developed and implemented chemical genomics tools to explore polydrug addiction networks. Our established cannabinoid molecular information database (CBID or CBLigand), a chemogenomics platform for cannabinoid research, was used to demonstrate the detailed application of these technologies. We also provide our perspective on the challenges in polypharmacology research and possible solutions.The in silico technologies for polypharmacology research can predict possible off-targets to avoid adverse effects, to suggest new targets of approved drugs for drug repurposing, and even to evaluate in silico affinity and selectivity among protein families.

AB - Polypharmacological effect is a prevalent problem for abused substances and is a challenge for research on drug abuse (DA). In silico technologies have emerged as effective approaches to study the interactions between small molecules and their potential targets.We focus on the contemporary resources and computational tools for polypharmacology research on DA. Specifically, we review current in silico techniques for pharmacology profiling of chemical compound(s). As an illustration, we used our developed and implemented chemical genomics tools to explore polydrug addiction networks. Our established cannabinoid molecular information database (CBID or CBLigand), a chemogenomics platform for cannabinoid research, was used to demonstrate the detailed application of these technologies. We also provide our perspective on the challenges in polypharmacology research and possible solutions.The in silico technologies for polypharmacology research can predict possible off-targets to avoid adverse effects, to suggest new targets of approved drugs for drug repurposing, and even to evaluate in silico affinity and selectivity among protein families.

KW - Cannabinoid drug abuse

KW - Chemogenomics knowledgebase

KW - Molecular docking

KW - Systems pharmacology

KW - TargetHunter

UR - http://www.scopus.com/inward/record.url?scp=84978354778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978354778&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800634-4.00019-6

DO - 10.1016/B978-0-12-800634-4.00019-6

M3 - Chapter

AN - SCOPUS:84978354778

SN - 9780128006344

VL - 3

SP - 183

EP - 195

BT - General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions

PB - Elsevier Inc.

ER -